FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

Cardiovascular and Renal Drugs Advisory Committee

Hilton Washington DC North/Gaithersburg

Gaithersburg Maryland

 

SLIDES

April 26, 2006

8:00 A.M. – 12:00 P.M.

The committee will discuss the agency’s draft recommendations for relabeling of antihypertensive drugs for outcome claims, as a follow-up to the committee’s meeting on June 15, 2005, where the committee discussed class labeling of antihypertensive drugs based on the proximity of their data to outcome trials

OPEN PUBLIC HEARING SPEAKERS 

 

Merrill Goozner, Center for Science in the Public Interest, Washington, DC (pdf)

William R. Hiatt, M.D. (No formal written presentation provided)

John M. Flack, M.D., M.P.H. (No formal written presentation provided)

Up | AC Home Page

Page last updated May 9, 2006 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management